X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (125) 125
female (104) 104
middle aged (69) 69
oncology (67) 67
adult (65) 65
breast neoplasms - drug therapy (63) 63
antineoplastic combined chemotherapy protocols - therapeutic use (56) 56
aged (45) 45
breast cancer (38) 38
breast neoplasms - surgery (38) 38
cyclophosphamide - administration & dosage (35) 35
breast neoplasms - pathology (33) 33
combined modality therapy (33) 33
chemotherapy (32) 32
breast neoplasms - mortality (30) 30
doxorubicin - administration & dosage (30) 30
methotrexate - administration & dosage (30) 30
follow-up studies (29) 29
chemotherapy, adjuvant (28) 28
fluorouracil - administration & dosage (28) 28
mastectomy (27) 27
treatment outcome (25) 25
index medicus (24) 24
prognosis (23) 23
therapy (23) 23
time factors (22) 22
cyclophosphamide (21) 21
disease-free survival (21) 21
survival analysis (21) 21
male (20) 20
breast neoplasms - therapy (18) 18
cancer (18) 18
clinical trials as topic (18) 18
lymphatic metastasis (18) 18
neoplasm staging (17) 17
prospective studies (17) 17
doxorubicin (16) 16
methotrexate (16) 16
neoplasm metastasis (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
randomized controlled trials as topic (14) 14
antineoplastic agents - therapeutic use (13) 13
drug therapy, combination (13) 13
fluorouracil (13) 13
vincristine - administration & dosage (13) 13
adjuvant chemotherapy (12) 12
cyclophosphamide - therapeutic use (12) 12
menopause (12) 12
adolescent (11) 11
medicine, general & internal (11) 11
neoplasm recurrence, local (11) 11
prednisone - administration & dosage (11) 11
recurrence (11) 11
surgery (11) 11
survival (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
bleomycin - administration & dosage (10) 10
disease progression (10) 10
hodgkin disease - drug therapy (10) 10
radiotherapy (10) 10
retrospective studies (10) 10
survival rate (10) 10
carcinoma (9) 9
care and treatment (9) 9
doxorubicin - adverse effects (9) 9
proportional hazards models (9) 9
remission induction (9) 9
research (9) 9
risk factors (9) 9
cancer therapies (8) 8
doxorubicin - therapeutic use (8) 8
drug administration schedule (8) 8
fluorouracil - therapeutic use (8) 8
follow-up (8) 8
hodgkin disease - therapy (8) 8
metastasis (8) 8
methotrexate - therapeutic use (8) 8
neoadjuvant therapy (8) 8
tumors (8) 8
adjuvant treatment (7) 7
antineoplastic agents - administration & dosage (7) 7
combination chemotherapy (7) 7
disease (7) 7
diseases (7) 7
paclitaxel (7) 7
patients (7) 7
preoperative chemotherapy (7) 7
receptors, estrogen - analysis (7) 7
trastuzumab (7) 7
aged, 80 and over (6) 6
analysis (6) 6
cyclophosphamide - adverse effects (6) 6
docetaxel (6) 6
dormancy (6) 6
hodgkin's disease (6) 6
medicine & public health (6) 6
paclitaxel - administration & dosage (6) 6
random allocation (6) 6
relapse (6) 6
trial (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9938, pp. 164 - 172
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 25 - 32
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 791 - 800
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 640 - 647
Journal Article
The Lancet Oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 249 - 256
In the neoadjuvant setting, blockade of HER2 plus use of an aromatase inhibitor in patients with HER2-positive and oestrogen receptor (ER)-positive breast... 
LAPATINIB | TRIAL | WOMEN | MULTICENTER | EFFICACY | ONCOLOGY | SAFETY | ENDOCRINE THERAPY | KI67 | COMBINATION | Antimitotic agents | Medical research | Analysis | Estrogen | Clinical trials | Medicine, Experimental | Breast cancer | Antineoplastic agents
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9712, pp. 377 - 384
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
by Asselain, Bernard and Barlow, William and Bartlett, John and Bergh, Jonas and Bergsten-Nordström, Elizabeth and Bliss, Judith and Boccardo, Francesco and Boddington, Clare and Bogaerts, Jan and Bonadonna, Gianni and Bradley, Rosie and Brain, Etienne and Braybrooke, Jeremy and Broet, Philippe and Bryant, John and Burrett, Julie and Cameron, David and Clarke, Mike and Coates, Alan and Coleman, Robert and Coombes, Raoul Charles and Correa, Candace and Costantino, Joe and Cuzick, Jack and Danforth, David and Davidson, Nancy and Davies, Christina and Davies, Lucy and Di Leo, Angelo and Dodwell, David and Dowsett, Mitch and Duane, Fran and Evans, Vaughan and Ewertz, Marianne and Fisher, Bernard and Forbes, John and Ford, Leslie and Gazet, Jean-Claude and Gelber, Richard and Gettins, Lucy and Gianni, Luca and Gnant, Michael and Godwin, Jon and Goldhirsch, Aron and Goodwin, Pamela and Gray, Richard and Hayes, Daniel and Hill, Catherine and Ingle, James and Jagsi, Reshma and Jakesz, Raimund and James, Sam and Janni, Wolfgang and Liu, Hui and Liu, Zulian and Lohrisch, Caroline and Loibl, Sibylle and MacKinnon, Liz and Makris, Andreas and Mamounas, Eleftherios and Mannu, Gurdeep and Martín, Miguel and Mathoulin, Simone and Mauriac, Louis and McGale, Paul and McHugh, Theresa and Morris, Philip and Mukai, Hirofumi and Norton, Larry and Ohashi, Yasuo and Olivotto, Ivo and Paik, Soon and Pan, Hongchao and Peto, Richard and Piccart, Martine and Pierce, Lori and Poortmans, Philip and Powles, Trevor and Pritchard, Kathy and Ragaz, Joseph and Raina, Vinod and Ravdin, Peter and Read, Simon and Regan, Meredith and Robertson, John and Rutgers, Emiel and Scholl, Suzy and Slamon, Dennis and Sölkner, Lidija and Sparano, Joseph and Steinberg, Seth and Sutcliffe, Rosemary and Swain, Sandra and Taylor, Carolyn and Tutt, Andrew and Valagussa, Pinuccia and van de Velde, Cornelis and van der Hage, Jos and Viale, Giuseppe and von Minckwitz, Gunter and ... and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) and GROCTA Trialists and EBCTCG
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 27 - 39
Journal Article
Journal Article